General experimental conditions
Dansylsarcosin was provided by Eul Hyun Suh. Warfarin and male human blood serum were purchased from Sigma and FluoZin TM -1 tripotassium salt was obtained from Invitrogen, Carlsbad, CA. All other reagents and solvents were acquired from commercial sources and were used as received. Analytical and semi-preparative HPLC was performed on a Hewlett Packard Series 1200 system using a Jupiter 5μ C18 300 Å 4.6 mm x 250 mm 5 microns (for analytical) or Jupiter 10μ C18 300 Å 10 mm x 250 mm 5 microns column (for semi-preparative) from Phenomenex. Typical separation procedure was carried out at room temperature with an isocratic or gradient of water/acetonitrile containing 0.1%/0.08% Trifluoroacetic acid (TFA) respectively unless indicated otherwise. Detection was done at 215 and 250 nm and a flow of 1 mL min -1 (analytical) or 4.7 mL min -1 (semipreparative) was used. T 1 's were measured using a Maran Ultra NMR relaxometer operating at 23 MHz (Oxford Instruments Molecular Biotools, Austin, TX). Longitudinal relaxivity values were determined from the slope of the line of the reciprocal of T 1 versus the concentration of gadolinium. Longitudinal relaxivity values were determined from the slope of the line of the reciprocal of T 1 versus the concentration of gadolinium according to equation (1) [ ]
where T 0 is the diamagnetic relaxation time which was set constant to 3.2 s as determined at 23 MHz for a solution of Tris buffer 0.1 M, pH 7.6 at 37 °C.
A 5 mM solution of the gadolinium complex was made up in Tris buffer 0.1 M pH 7.6. This was serially diluted four times to give five different sample concentrations (5, 4, 3, 2, and 1 mM) at a [Gd] All mouse treatments were done according to the standards of the UT Southwestern Institutional Animal Care and Use Committee (IACUC). Male blk6 normal mice at 8-10 weeks old were obtained for use in this study and conditioned in their new environment for at least 2 weeks in the regular chow diet before any feeding regimen and imaging were done.
All MR images (fast spin-echo multi-slice sequence, FSEMS) were obtained on a 9.4 T (400-MHz) horizontal-bore Varian INOVA imaging system with a dual-channel 38-mm diameter birdcage volume coil. analysis were done by Galbraith Laboratories, Inc (Knoxville, TN).
ICP-OES Gd
All fluorescence measurements were performed in SpectraMax M5 Microplate Reader from Molecular Devices.
Curve fitting was done with GraphPad Prism Software Version 5.04 (Graph Pad Software Inc.).
Image analyses were carried out using ImageJ 1.41o software provided by the National Institutes of Health, USA.
Synthesis
The synthesis of 1,4,7,10-Tetraazacyclododecane-1,4 -bis(tert-butyl acetate)-7,10-acetic acid (DOTA-bis-tert butyl ester), was accomplished according to De León-Rodríguez et al. Synthesis of Pyrazole-3-carboxylic acid (2) 3-methylpyrazole (1) (5.24 g, 63.7mmol) was dissolved in 200 mL Milli Q grade water followed by slow addition of 75 mL aqueous KMnO 4 (22g, 2.2 equiv.) at room temperature. Mixture was refluxed for 4 hours, a color change from purple to brown was observed indicating the completion of the oxidation process. Reaction mixture was cooled down to room temperature and then filtered. The pH of the filtrate was decreased from 10.6 to 1.7 by adding concentrated HCl. A white solid precipitated upon acidification of the filtrate.The solid was filtered out and washed with cold concentrated HCl. 3.512 g of product were collected upon drying corresponding to a 49% yield. 
Synthesis of 3-(chloromethyl)pyrazole.HCl (4)
Pyrazole-3-carboxylic acid (2) (1.94g, 17.3 mmol) was dissolved in 40 mL of dry THF under N 2 followed by addition of BH 3 (64mL, 1M) in THF. Reaction mixture was stirred at room temperature for 2 hours, then at 40 °C for 1 hour and then it was allowed to cool down to room temperature. 50 mL of Milli Q grade water were slowly added and the resultant mixture was stirred overnight at room temperature. Solution was concentrated to 30 mL by rotary evaporation and residue was washed with dichloromethane 2x 20 mL. The aqueous phase was collected and concentrated to 5 mL and a white solid was observed. Solid was recrystallized, filtered and dried giving 3-(hydroxymethyl)pyrazole (3) quantitatively (1.70 g). The obtained solid is very hygroscopic and was used immediately without further characterization. 5 mL of neat thionyl chloride were added to (3) and mixture was stirred overnight at room temperature. 10 mL of Milli Q water were added to the reaction mixture and resultant solution was stirred for 1 hour to eliminate the excess of thionyl chloride. Solution was filtered out, the filtrate was collected and solvent was removed under high vacuum resulting in a transparent oil. The oil was dried further adding 20 mL of dichloromethane followed by its removal by rotary evaporation. This procedure was repeated 4 times giving a white solid that upon drying under high vacuum gave 2.467 g which correspond to 93.2% yield as for the HCl salt of the product. 
Synthesis of N-(2-pyrazolylmethyl) ethylene diamine (5)
N-Boc-ethylendiamine (430 mg, 2.684 mmol) was dissolved in 40 mL of acetonitrile under N 2 atmosphere followed by addition of 3-chloromethylenepyrazole (914 mg, 2 equiv.) and K 2 CO 3 (2.967 mg, 8 equiv.). Resultant mixture was refluxed for 52 hours under N 2 . Mixture was filtered and the solvent was removed from the filtrate under rotary evaporation. Product was purified by HPLC (isocratic 65%/35% water/acetonitrile containing 0.1%/0.08% TFA, Rt = 6.34 min) which after liophilization gave 694 mg of a white solid (81%) which corresponded to the trifluoroacetate salt of N-Boc-N´-(2-pyrazolylmethyl) ethylene diamine. Synthesis of 1,4,7,10-Tetraazacyclododecane-1,4 -bis(N,N-bis(2-pyrazolylmethyl) aminoethyleneacetamide)-7,10-acetic acid, DOTAdiBPYREN 1,4,7,10-Tetraazacyclododecane-1,4-bis(tert-butyl acetate)-7,10-acetic acid (DOTA-bistert butyl ester ) (530 mg, 1.025 mmol), HBTU (808 mg, 2.13 mmol) and 200 μL of DIPEA were dissolved in 5 mL of DMF and the resultant yellow solution was stirred for 5 min at room temperature. The previous mixture was added to a 5 mL DMF solution containing N-(2-pyrazolylmethyl) ethylene diamine. 2HCl 631 mg (2.15 mmol) and 2.5 mL (26.6 mmol) of DIPEA. The resultant mixture was stirred overnight at room temperature. Solvent was removed under vacuum while heating at 50°C. 20 mL of dichloromethane were added to the residue and the mixture was washed with a 0.15 mM NaOH aqueous solution and the organic phase was collected. The basic washing was repeated 4x 25 mL, followed by one washing with 25 mL of Milli Q grade water. The organic phase was collected, dried with anhydrous Na 2 SO 4 , filtered and the solvent was removed by rotary evaporation. Product was purified by HPLC (H 2 O/ACN 83/17 containing 0.1%/0.08% TFA as the eluent under isocratic conditios, R t = 9.08 min). The fraction containing the compound was freeze-dried giving 368 mg of product (39% 1,4,7,10-Tetraazacyclododecane-1,4-bis(N,N-bis(2-pyrazolylmethyl) aminoethyleneacetamide)-7,10-bis(tert-butyl acetate) (368 mg) was dissolved in TFA 95% in Milli Q grade water and stirred at room temperature for 2 hours. Solvent was removed under a gentle N 2 flow and residue was dissolved in Milli Q water and then it was freeze-dried giving 262 mg of the ligand as a white solid of the bis-trifluoroacetate salt. 
Synthesis of Gd

3+
DOTA-diBPYREN (6) DOTA-diBPYREN (86 mg, 0.083 mmol) was dissolved in MilliQ grade H 2 O and the pH adjusted to 6.5 with 1 M NaOH. GdCl 3 •6H 2 O (0.085 mmol) dissolved in water was slowly added in slight excess. The pH of the solution was maintained between 6 and 6.5 during addition. The resultant solution was stirred at room temperature for several hours and pH adjusted close to 6.5 as needed. Unreacted Gd 3+ was precipitated as Gd(OH) 3 after the addition of 1 M NaOH and solution was filtered through a teflon 0.22μ filter. Gd content was assessed by ICP-OES and this was used to determine the amount of unsalted GdDOTA-diBPYREN (95.8% yield). The absence of free Gd was determined with the Xylenol Orange test.
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The absence of fee ligand was determined via analytical HPLC using aqueous (NH4)2CO3 5 mM pH 8/MeOH (50/50) 2 mM and then without. Another titration was performed in the same buffer with only GdDOTA-diBPYREN 1 mM. The T 1 values were recorded in all cases. Association constant was determined considering the following equilibrium and equations (2) to (4): [GdLZn] is the concentration of unbound GdDOTA-diBPYREN or GdDOTAZn 2 diBPYREN in solution.
[HSA] is the concentration of free HSA in solution.
[HSA] O is the total concentration of HSA. ΔR is the relaxation rate enhancement. R b is the maximum value that the relaxation rate enhancement can reach extrapolated to the scenario where all the contrast agent is bound to HSA. R 1,obs is the determined relaxation rate (1/T 1 ) of the contrast agent in buffer or in buffer with HSA. R 1,d is the diamagnetic relaxation rate of buffer with HSA.
HSA titration with GdDOTA-diBPYREN was fitted to a one site -Fit total and nonspecific binding model in GraphPad Prism (equation 4). Fitting parameteres are shown below in Table S1 , where B max is R b , NS is the slope of nonspecific binding, background is the amount of nonspecific binding with no added competitor. and K D is given in the same units as [HSA] . 
Fluorimetric determination Zn
2+
binding dissociation constant to GdDOTAdiBPYREN 5.1 Saturation binding experiment A series of solutions containing 10 uM ZnCl 2 in tris buffer 0.1 M pH 7.6 each with increasing concentrations of Fluozin-1 (Invitrogen); 0 uM , 2 uM, 4 uM , 6 uM, 8 uM, 10 uM, 12 uM, 14 uM , 16 uM, 18 uM, 20 uM and 24 uM were prepared by duplicate. After mixing all solutions were allowed to stabilize for 30 minutes at room temperature. The fluorescence of 100 µL aliquots of each of these samples was measured in duplicate in 96 well plates, the excitation and emission wavelengths used were 495 and 517 nm, respectively. The Zn Table S3 and fitted data is shown in Fig. S8 . 
Competition binding experiment
A solution containing 10 µM of FluoZin-1, 10 µM ZnCl 2 and 200 µM GdDOTAdiBPYREN in buffer was prepared. Aliquots of this solution were 3-fold diluted serially by addition of a buffered solution which contained the same concentration of FluoZin-1 and ZnCl 2 but without agent. This gave fourteen samples of different concentrations of agent (differing by a factor of 3), but all containing the same concentration of FluoZin-1 and ZnCl 2 , samples were prepared by duplicate. The fluorescence of 100 µL aliquots of each of these samples was measured in duplicate in 96 well plates. In a similar manner solutions containing agent, ZnCl 2 but no fluorescent probe were prepared and fluorescence measured by duplicate in order to account for any signal coming from the agent interacting with Zn 
Where:
F is the measured corrected fluorescence. Competition data was fitted to a one site -Fit K i model in GraphPad Prism (equations 6 and 7). Fitted data is shown in Figure S9 and fitted parameteres are shown in Table S4 , where bottom is F min , top is F max , HotNM is [FP] O , HotKdM is K D both in nM units and K´D is given in the same units as of [Competitor] o .
